Russia will have its own generic of one of the world’s most expensive drug against cystic fibrosis, as the Russian ...

US biotech Biogen has received US Food and Drug Administration (FDA) Breakthrough Therapy designation for salanersen, its ...

US biotech Stipple Bio has signed a multi-target licensing agreement with Swiss life sciences supplier Lonza to support ...

UK privately-held AMR Bio has submitted written comments to the Presidential Advisory Council on Combating ...

The 2026 American Society of Clinical Oncology (ASCO) annual meeting delivered several potentially practice-changing datasets ...

Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, ...

Israel-headquartered Teva Pharmaceutical Industries has announced the launch of Ahzantive (aflibercept), a biosimilar to ...

US drugmaker Gilead Sciences today announced that the UK’s National Institute for Health and Care Excellence (NICE) has ...

Belgian biopharma UCB (Euronext Brussels: UCB) and US biotech Biogen (Nasdaq: BIIB) have reported further Phase III data for ...

Australian clinical-stage biotech Neurizon Therapeutics is expanding the NUZ-001 arm of the HEALEY ALS Platform Trial after ...

Shares of US biopharma company Cingulate closed up 11.9% at $4.03 on Tuesday, after it announced that the US Food and Drug ...

Spanish biotech Ona Therapeutics has raised $87 million in an oversubscribed series B round, giving the Barcelona company the ...